Image_3_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image_2_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image_2_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image_5_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image_4_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image_3_Preclinical evidence of a direct pro-survival role of arginine deprivation in multiple myeloma.tiff by Matteo Trudu (13758211)

“…Arginase inhibition significantly raised serum arginine concentration, reduced tumor growth by caliper assessment, and decreased intra-tumor AKT phosphorylation in vivo. …”

Image 2_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”

Image 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.tiff by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”

Table 1_Enhanced cognitive control following neurofeedback therapy in chronic treatment-resistant PTSD among refugees: a feasibility study.pdf by Mirjana Askovic (6562304)

“…Post-treatment, clients were categorised into Responders and Non-Responders, with responders defined as those achieving a clinically significant reduction in PTSD symptoms (≥0.5-point decrease on the HTQ).…”

Image2_Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients.tif by Yueying Chen (8708796)

“…</p><p>Results: PNR occurred in 31.06% (100 of 322) patients who were assessable at week 14. IL-6 levels significantly decreased after IFX therapy (p < 0.001). …”

table3_Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients.docx by Yueying Chen (8708796)

“…</p><p>Results: PNR occurred in 31.06% (100 of 322) patients who were assessable at week 14. IL-6 levels significantly decreased after IFX therapy (p < 0.001). …”

table1_Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients.docx by Yueying Chen (8708796)

“…</p><p>Results: PNR occurred in 31.06% (100 of 322) patients who were assessable at week 14. IL-6 levels significantly decreased after IFX therapy (p < 0.001). …”

Image1_Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients.tif by Yueying Chen (8708796)

“…</p><p>Results: PNR occurred in 31.06% (100 of 322) patients who were assessable at week 14. IL-6 levels significantly decreased after IFX therapy (p < 0.001). …”

table2_Development and Validation of an Interleukin-6 Nomogram to Predict Primary Non-response to Infliximab in Crohn’s Disease Patients.docx by Yueying Chen (8708796)

“…</p><p>Results: PNR occurred in 31.06% (100 of 322) patients who were assessable at week 14. IL-6 levels significantly decreased after IFX therapy (p < 0.001). …”

Supplementary Material for: Expression of Insulin-like Growth Factor Type 1 Receptor is Linked to Inflammation in Adamantinomatous Craniopharyngioma by Yang L. (3635365)

“…Results Patients in the IGF1R high expression group had a significantly higher incidence of hypopituitarism, higher recurrence rate and lower progression-free survival. …”

Daylight saving time (DST) shifts appear to affect the relative risk (RR) of numerous diseases spanning several human biological systems. by Hanxin Zhang (4280524)

“…For the Swedish tests, negative controls were performed on data before 1980 when DST was not observed in Sweden. We selected all depicted signals automatically (see <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1007927#pcbi.1007927.s001" target="_blank">S1 Appendix</a> Section 2.1), as the significant RR largest in effect size that were: (1) significantly greater than one in the spring DST shift analyses (colored), and: (2) <i>not</i> significantly greater than one in the negative control (gray) analyses, or <i>vice versa</i> for decreased signals. …”

Data_Sheet_1_Tranexamic Acid for Acute Spontaneous Intracerebral Hemorrhage: A Meta-Analysis of Randomized Controlled Trials.docx by Yu Guo (102701)

“…</p><p>Conclusions: Tranexamic acid (TXA) may decrease the risk of HE in patients with acute spontaneous ICH. …”

Data_Sheet_1_Oral Supplementation With Butyrate Improves Myocardial Ischemia/Reperfusion Injury via a Gut-Brain Neural Circuit.PDF by Zhiyao Yu (10821540)

“…</p><p>Results: Butyrate treatment significantly reduced the infarct size and decreased the expression of creatine kinase (CK), creatine kinase myocardial isoenzyme (CK-MB), and lactate dehydrogenase (LDH) compared with the values found for the I/R group. …”

Table 1_Efficacy of the early start Denver model combined with the TEACCH program in children with autism spectrum disorder.docx by Ling-Ling Ma (7894544)

“…Baseline comparability was confirmed by the Chinese version of the Childhood Autism Rating Scale (CCARS).</p>Results<p>Both groups showed significant within-group improvement after intervention, but the combined observation group demonstrated greater gains. …”

Repression of YEATS2 induces cellular senescence in hepatocellular carcinoma and inhibits tumor growth by Qi Wu (263110)

“…<p>Hepatocellular carcinoma (HCC) stands as the third leading cause of cancer-related fatalities globally. In this study, we observed a significant increase in the expression level of the <i>YEATS2</i> gene in HCC patients, and it is negatively correlated with the patients’ survival rate. …”